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SUMMARY
A sensitive, reproducible and rapid analytical method that is capable of identifying the
presence of lung damage at an early stage is required, We have developed a sensitive enzyme-
linked immunosorbent assay for desmosine in human body fluids. An amino group of des-
mosine was exclusively linked to bovine gamma globulin and the high-titer antibody to this
conjugate was prepared. This antibody was used in this assay. This method enables the
routine analysis of large numbers of samples with a detection limit of O. 4 ng desmosine. Using
this method, we quantitatively measured desmosine in the urine of 8 normal controls and 25
patients with chronic obstructive lung disease. The results were expressed as desmosine/creatine
ratio. On average, a statistically significant higher level of desmosine/creatinine was found in
the patients compared to the controls.
INTRODUCTION
Pulmonary emphysema usually develops insidiously over many years, and significant damage
to lung tissue has already occurred before the chest X-ray and the pulmonary function tests
become abnormal. For this reason, an analytical method that is capable of identifying the
presence of lung damage at an early stage, before conventionary detectable symptoms develop, is
required. It could be useful in identifying those people who are at risk and possibly in moni-
toring the progression of the disease.
This disease is characterized by a progressive destruction of alveolar walls. Elastin is one
the major components of lung connective tissue and is responsible for maintaining its elasticity
(1, 2). When the connective tissue is destroyed, elastin is released from the lungs to the body
fluids as elastin peptides (2, 3). Unusual changes in the concentration of elastin degradation
products in body fluids may indicate the progression of the pulmonary destruction. Therefore,
sensitive assay methods are necessary to monitor the concentration of these products in body
fluids. So far, the approaches which have been used for this purpose are tests for the elastin-
specific crosslinking amino acids, desmosine (4, 5) and isodesmosine (6), or elastin peptides
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(7, 8).
Darnule et al. (7) developed a radioimmunoassay to determine the elastin peptide content
of human serum. Kucich et al. (8) made antibodies for peptides derived from human lung
parenchymal elastin and used these antibodies in an enzyme-linked immunosorbent assay
(ELISA)! to quantify elastin peptides in human serum. However, the structures and properties
of elastin peptides in human body fluids are not yet clear. Desmosine and isodesmosine are
known as specific crosslinking amino acids of elastin, and thier structures and properties have
been identified (9-12). Therefore, the measurement of urinary desmosine could provide a true
monitor of elastin turnover. Harel et al. (5) described a radioimmunoassay for detecting des-
mosine in acidhydrolysates of urine. Skinner et al. (6) developed a radioimmunoassay for the
determination of isodesmosine. Urinary desmosine excretion is known to rise as a result of
increased elastin degradation in the body.
Expensive equipment and radioactive materials have been used in the immunoassays performed
for the determination of desmosine (4, 5) or isodesmosine (6). ELISA, on the other hand, is
cheaper and safer, since the assay does not require radioactive materials. We have avoided the
use of radioisotopes and developed a double antibody ELISA for the determination of desmosine
in an acid hydrolysate of urine.
For this purpose, we prepared the desmosine derivative of which an ammo group was
substituted exclusively by a heterobifunctional coupling reagent (13). The antiserum for the con-
jugate obtained from this derivative and a carrier protein showed high-titer and good specificity
in the ELISA. The assay was found to be suitable for accurate estimation of elastin degrada-
tion products in human urine. We measured desmosine excretion in normal controls, and in a
group of patients with chronic obstructive lung disease (COLD).
MATERIALS AND METHODS
Chemicals. Bovine ligamentum nuchae elastin was purchased form Worthington (USA);
bovine gamma globulin (BGG, labile enzyme free fraction II) from Miles Labs (USA); keyhole
limpet hemocyanin (KLH) from Calbiochem-Behring Corp. (USA); N-succinimidyl 3-(2-pyridyl-
dithio) propionate (SPDP) from Pharmacia Fine Chemicals (Sweden); alkaline phosphatase
labeled goat antirabbit IgG from Miles-Yeda (USA). All other chemicals were of the highest
analytical grade available.
The type of microtitration plates used was flatbottom N unc-Immuno plate I. Corona
MTP-12 two waves microplatephotometer was used for the measurement of uv-absorption.
Purification of desmosine and isodesmosine. The fraction containing desmosine and isodes-
mosine was obtained from acidhydrolysates of elastin using Franzblau's method (14). Elastin
was hydrolyzed in 6. 0 M hydrochloric acid under reflux for 48 h. The hydrolysate was evaporated
to dryness, redissqlved in water and placed on a Dowex 50-X8 column (4. 5 X 17 cm). Elution was
carried out with 1 liter of 1. 5 M hydrochloric acid, followed by 5 liters of 2. 5 M hydrochloric
1 Abbreviations used: BGG, bovine gamma globulin; COLD, chronic obstructive lung disease; DIC,
desmosine/creatinine; DTT, dithiothreitol; ELISA, enzyme linked immunosorbent assay; KLH, keyhole
limpet hemocyanin; PT, pyridine-2-thione; SIMS, secondary ion mass spectrometry; SPDP, N -succinimidyl
3-(2-pyridyldithio) propionate; TCA, trichloroacetic acid.
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acid, and finally 6 liters of 4. 0 M hydrochloric acid in which the eluted desmosine and
isodesmosine were in solution.
Isolation of desmosine and isodesmosine from this mixture was carried out using Ledvina
and Bartos' method (15) by which the mixture was repeatedly evaporated to dryness, dissolved
in 0.38 M citrate buffer (pH 4. 35) and applied to an AG50WX4 column (0. 6 X 60 em) equilibrated
with the buffer. Elution was performed with the buffer at a How rate of O. 1 ml/min. Eluant
fractions were monitored by uv-absorption spectrophotometry, and the isodesmosine fraction and
the desmosine fraction were obtained. Each fraction was desalted on an AG50W X8 column
(1. 6 X 30 em) using 1 M ammonium hydroxide as the eluting solvent, and evaporated to dryness.
After that each compound was dissolved in O. 1 M acetic acid, applied to a Bio-Gel P-2 column
(2. 5 X 91 em), eluted with the solvent, and lyophilized to give desmosine acetate or isodesmosine
acetate as a yellowish powder.
These compounds were identified by IH-NMR spectroscopy (500 MHz) and secondary ion
mass spectrometry (SIMS), and their purities were checked by HPLC (Partisil 10SCX, 4. 6 X 250
mm; 10% acetonitrile-O. 05 M ammonium acetate, pH 4.0). This highly purified desmosine was
used for the next conjugation step and as a reference standard. Highly purified isodesmosine
was used for testing cross-reaction.
Preparatz"on 0/ desmosz"ne-protez"n conjugates. Two conjugates were prepared. The conjugate
to be used as immunogen was made with BGG and the coating conjugate with KLH. The
immunogen was synthesized using a heterobifunctional coupling reagent. The coating conjugate
was synthesized by the carbodiimide method.
(a) Preparation of SPDP-monoacylated desmosine: Desmosine acetate (38 mg, 65 ]-tmol) was
dissolved in 25 ml of O. 05 M phosphate buffer (pH 5. 9) containing O. 1 M N aCI. SPDP (21 mg,
68/-tmol) dissolved in 3 ml of ethanol was then added dropwise to the stirred desmosine solution.
The reaction mixture was stirred for 3 h at room temperature and the resulting mixture was
evaporated. The dry residue was then dissolved in 5 ml of O. 1 M acetate buffer (pH 4. 5) and
the solution was applied to a column (1. 5 x90 em) of Sephadex G-25 superfine equlibrated
with the acetate buffer at room temperature. The elution was performed with the buffer at a
flow rate of O. 1 ml/min (Fig. 1). Eluant fractions (3 ml/tube) were monitored by uv-absorption
and HPLC. These groups of fractions gave characteristic uv-avsorption spectra (N. 26-29), A269
nm; No. 33-35, A277 nm; No. 38-40, A277 nm). The first group of fractions (No. 26-29)
contained free desmosine. Two desmosinc derivatives were found in the second group (No.
33-35) and 1ll the third group (No. 37-40). When O. 1 ml of 50 mM aqueous dithiothreitol
(DTT) was added to small aliquots of these fractions, fractions in the latter two groups showed
a new uv-absorption at 343 nm by released pyridine-2-thione CPT). By comparing with the uv-
spectra before this reaction, these derivatives were shown to be SPDP-monoacylated desmosine
and di-SPDP-acylated desmosine. The fractions in the secOIhl group containing only SPDP-
monoacylated desmosine were combined and desalted by passing through a Bio-Gel P-2 column
(2. 5 X 91 em). Elution was performed with O. 1 M acetic acid and eluant fractions were moni-
tored by uv-absorption and HPLC. The fractions containing the c1esmosine derivative were
again combined and the acetic acid was removed by evaporation. The residue was redissolved
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Table 1. Comparison of SPDP-monoacylated desmosine (II) and desmosine (I)
in NMR chemical shifts.
I II Assignments

















1. 96-2. 11 (m, 4H)
2.17 (m,4H)
2.78 (m,2H)
2. 90 (m, 4H) }
3.02 (m,2H)
3.12 (t, 2H)




















1. 98 (s, 3H)
1. 89 (m,2H)
2.00-2. 10 (m, 4H)
2.17 (m,4H)
NMR spectra were recorded on a BRUKER AM-500 (500MHz) and are given
in parts per million (ppm) downfield shift from the internal standard, sodium 2,
2-dimethyl-2-silapentane-5-sulfonate, in deuterium oxide. Assignment as shown
above were allowed by comparison with values given in other works (11).
Abbreviation: s, singlet; t, triplet; m, multiplet.
I. R=H
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in distilled water and lyophilized to give SPDP-monoacylated desmosine acetate as a yellowish
powder (15. 6 mg, 20.umol).
The number of 2-pyridyl disulfide groups in the desmosine derivative was determined by
measuring the molecular mass of the desmosine derivative and the amount of PT released by
the reaction with DTT. The molecular mass (M+ =723) was obtained by SIMS. The desmosine
derivative (2 mg, 2. 6 .umol) was then dissolved in 3 ml of 50 mM aqueous DTT and stirred at
room temperature. After 2 h, when the reaction was almost complete, the uv-absorption at 343 nm
was measured. The amount of PT released was calculated to be 2. 6 .umol from the uv-absorption
and the molar absorptivity of PT (8. 08X1, 000 at 343 nm) (13). The structure of SPDP-mono-
acylated desmosine acetate was identified by IH-NMR spectroscopy (500 MHz) (Table 1).
(b) Preparation of desmosine-BGG conjugate: BGG (100 mg) was dissolved in 5 ml of 6 M
quanidine hydrochloride containing 0.5 M tris-buffer (pH 8. 1) and 0.02 M EDTA, and the
solution was kept at 50°C for 30 min under N 2 gas flow. After 103 mg of DTT had been
added, this solution was stirred for 4 h again under N 2 gas flow. The volume of the solution
was restored to 5 ml with distilled water and then 5 ml of 10% trichloroacetic acid (TCA) was
added. After being centrifuged (3,000 rpm, 10 min), thiolated BGG was obtained as a white
precipitate and lyophilized. This protein (20 mg) was dissolved in 10 ml of 6 M urea containing
0.1 M NaCI and 0.1 M phosphate buffer (pH 7.5), and 4.67 mg of the SPDP-monoacylated
desmosine acetate was added. The solution was stirred continuously for 45 min at room tem-
perature after which 15 ml of 10% TCA was added. A white precipitate was obtained after
centrifuging as before. After washing with 1 ml of distilled water, the precipitate was lyophilized
to give the conjugate as a white powder (11 mg). This time, after addition of 10% TCA to the
supernatant, precipitation did not occur. This conjugate was used for immunization.
The number of desmosine residues introduced per molecule of BGG was calculated from
the uv-absorption at 343 nm of released PT. If the molecular weight of the thiolated BGG was
taken to be 150,000, the number of introduced desmosine residues would become 10 per molecule
of BGG. The homogeneity of this desmosine-BGG conjugate was examined by passing through a
Sephadex G-100 column (1. 5 X 90 cm). This conjugate was eluted as a single peak using O. 1 M
phosphate buffer (pH 7.5) containing 0.1 M NaCl.
(c) Preparation of desmosine-KLH conjugate; KLH (60 mg) was added to 6 ml of O. 015 M
N aCI and undissolved material was removed by a centrifuge. A solution of desmosine (11. 3 mg)
dissolved in 3.0 ml of O. 01 M phosphate buffer (pH 7.0) was mixed with the KLH solution and
a further 100 mg of l-ethyl-3(3-dimethylaminopropyl)-carbodiimide hydrochloride. After stirring
for 20 h at room temperature, the solution was dialysed against water (12 liters) for 50 h. The
supernatant obtained using a centrifuge was lyophilized to give the desmosine-KLH conjugate as a
white powder (25. 5 mg).
Antisera to be the desmosl:ne-BGG conjugate. Two rabbits (male New-Zealand White) were
immunized against the desmosine-BGG conjugate. The conjugate (1. 5 mg) was dissolved in
0.3 ml of 8 M urea, mixed with 0.5 ml of 0.9% aqueous NaCI and emulsified with an equal
volume of Freund's complete adjuvant. This emulsion was injected, in six O. 15 ml portions,
into the rear foot pads. Nine days later, desmosine-BGG conjugate (1. 5 tng) emulsified with
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Freund's incomplete adjuvant was injected subcutaneously, in ten O. 1 ml portions, into the
back. The animals were then boosted for 3 months at two-week intervals with intravenous
injections of desmosine-BGG alone (0. 1 mg each). Ten days after the last injection, they were
bled. The serum was collected, and stored at 4°C in O. 1% sodium azide until ready for use.
Buffers for ELISA. (A) Coating conjugate dilution buffer: O. 1 M phosphate buffer,
pH 7. 4, containing O. 1 M N aCI and O. 1% sodium azide; (B) coating buffer: O. 05 M
carbonate/bicarbonate, pH O. 6, containing O. 1% sodium azide; (C) rinse buffer: phosphate-
buffered saline, pH 7. 4, containing O. 5% Tween 20 and O. 1% sodium azide; (D) sample dilution
buffer: O. 1 M phosphate buffer, pH 7. 0, containing O. 1 M N aCI and O. 1% sodium azide; (E)
antiserum dilution buffer: O. 1 M phosphate buffer, pH 7.4, containing 0.05% KLH, 0.1 M
N aCI and O. 1% sodium azide; (F) labeled IgG dilution buffer: O. 01 M phosphate buffer, pH
7.4, containing O. 15 M NaCI and O. 1% sodium azide; (G) substrate buffer: 10% diethanolamine
buffer, pH 9. 8, containing 0.2% sodium azide.
Enzyme-linked immunosorbent assay. Desmosine-KLH was dissolved in dilution buffer
(A) at 100,ug/ml. After being centrifuged to remove traces of undissolved material, the solution
was stored at 4°C until ready for use. This solution was diluted in coating buffer (B) at 2,ug/ml
immediately prior to use and 300,u1 was dispensed into each of the 60 inner wells of microti-
tration plates. The plates were then incubated at 4°C overnight. This solution was decanted from
the wells, and each plate was washed with 4 X 400 ,ul rinse buffer (C) and blotted. Serial dilutions
of desmosine and unknowns were made in sample dilution buffer (D). Duplicate or triplicate
aliquots of 100,u1 were placed into adjacent wells, a standard curve of desmosine and blanks of
100,u1 sample dilution buffer being included on each plate. One hundred micro liters of antiserum
diluted 1: 15, 000 in antiserum dilution buffer (E) were added to each well except for a "no
antibody" blank and 100,u1 dilution buffer alone added into the blank. After 18 h incubation
in a humid box at 4°C, the wells were emptied and the plates were washed and blotted as
before. A solution (200,u1) of alkaline phosphatase labeled goat anti-rabbit IgG diluted 1: 500
in F buffer was added to each well. The plates were incubated at 3rC for 3 h, emptied,
wahsed and blotted as before. In addition the plates were washed with 3 X 400,u1 double-
distilled water and blotted. A fresh solution of 4 mM p-nitrophenylphosphate was prepared in a
prewarmed substrate buffer (G) and 200,u1 dispensed to each well. After the solution had been
incubated for 90 min at 37°C, the color reaction was terminated by the addition of 50,u1 of 3 M
N aOH and then the absorbance at 405 nm was taken. A typical standard curve for desmosine
IS shown in Fig. 5 together with those of isodesmosine and lysine.
Subjects. The subjects were 25 patients with COLD and 8 healthy controls. The patient
group contained 15 males and 10 females, ranging in age from 22 to 76 years old. The diagnosis
of COLD was based on the definition of COLD described by American Thoracic Society (16).
Fourteen among 25 cases were smokers before realizing the disease. On the other hand, all of
the healthy controls were males, ranging in age from 23 to 39 years old and six were smokers.
Sample preparation. Urine was collected over a period of 24 h and, after mixing, 2 ml
samples were subjected to hydrolysis in 6 M hydrochloric acid (final concentration) at no°c for
72 h. The hydrolyzed samples were evaporated to dryness and redissolved in 15 ml of double-
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distilled water. These solutions were then adjusted to pH 7. a with 1 M N aOH and lyophilized.
After that, desmosines in the hydrolyzed samples were partially purified using Skinner's method
(17). A slurry was prepared by mixing CFll cellulose (10 g) with the mobile phase, n-butanol-
acetic acid-water (4:1:1) 200 m!. Columns (0. 7x20 cm) were then packed to about 5 cm height
by pipetting 5 ml of the slurry. A further 5 ml of mobile phase was added to each column.
After each lyophilized sample was redissolved in 2 ml of water, O. 5 ml of the solution was
mixed, in order of addition, with acetic acid (0. 5 ml), cellulose slurry (0. 5 ml) and n-butanol
(2 ml) in a vial. The slurry was transferred onto a prepared column and the vial washed with
2 ml mobile phase which was also transferred to the column. The column was then eluteel with
a further 15 ml mobile phase. The desmosines were eluteel from the column with water (10 ml)
inot a vial. After these aqueous fractions containing the desmosines were evaporated to dryness
and redissolved in 1 or 2 ml of D buffer, aliquots of O. 1 ml wwere used in the ELISA for
determination of desmosine.
Measurement of creatl:nine content. Creatinine content was measured on a second aliquot
from the same speciemn by automatic chemical analysis (18).
RESULTS
Preparation of desmosine z'mmunogen.
Since desmosine is not immunogenic in itself because of its low molecular weight, it has to be
coupled to larger molecules in order to make it suitable for immunization of animals. According
to other reports (4-6), desmosine and isodesmosine were coupled to carrier proteins using the
carbodiimide method. This coupling procedure is very simple and widely used. However,
since desmosine contains four alpha-amino groups and four alpha-carboxyl groups, the coupling
may be achieved by the formation of peptide bonels between carboxyl groups (and/or amino
groups) of desmosine and amino groups (and/or carboxyl groups) of a protein, and the resulting
conjugates contain a lot of products such as polymers of the reacting components and polycon-
jugates. In addition, the desired conjugates are difficult to purify for use. This may be why
high-titer antibodies have not been obtained using this method. In order to obtain a high-
titer antibody with good specificity, it is desireable to perform the coupling exclusively at only
one of the eight functional groups in desmosine.
Selective coupling of SPDP onto an amino group of desmosine was performed under a mild
aqueous condition (pH 5.9) with a limited amount of SPDP. The resultant mixture was chromato-
graphed on a column of Sephadex G-25 with O. 1 M acetate buffer (pH 4. 5). The elution profile
is shown in Fig. 1. The first group of fractions (No. 26-29) contained free desmosine, SPDP-
monoacylated desmosine was found in the second group (No. 33-35) and di-SPDP-acylated
desmosine was in the third group (No. 37-40). These were judged to be present from the uv-
spectra and the PT contained in the tubes.
The second group of fractions containing SPDP-monoacylated desmosine were combined and
desalted by passing through a Bio-Gel P-2 column. The desired compound after elution with
O. 1 M acetic acid was lyophilized to give a yellowish powder in a yield of 31%. The prepara-
tion was examined by HPLC which gave a single peak indicating its pruity. The molecular
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Fig. 1. Chromatogram of SPDP-acylated desmosine on Sephadex G-25 column. The uv-absorption
spectrum was determined for every fraction.
reaction with DTT. The amount of PT released is proportional to the number of 2-pyridyl
disulfide groups in the derivative. Thus, from these two results, the number of 2-pyridyl
disulfide groups in the derivative could be checked. SIMS gave the molecular mass (M+ =723)
equivalent to the molecular weight of SPDP-monoacylated desmosine. Furthermore, the amount
of PT released was equivalent to that of the desmosine derivative used in the reaction with
DTT. Thus the desmosine derivative was confirmed as SPDP-monoacylated desmosine. The
structure was identified by IH-NMR spectroscopy (500 MHz) and NMR signals of the protons
of SPDP-monoacylated desmosine acetate are summarized in Table 1 and compared with those
of desmosine acetate.
SPDP-monoacylated desmosine acetate was coupled to BGG thiolated by dithiothreitol as
described in MATERIALS AND METHODS via thiol-disulfide exchange in order to form
disulfide-linkage. The desired product, desmosine-BGG conjugate, was obtained as a white
powder in good yield. The desmosine-BGG was fairly homogeneous because this was eluted as a
single peak when passed through a Sephadex G-1DD column. The number of desmosine residues
introduced per molecule of BGG was calculated to be 10 from the amount of PT released as a
result of the thiol-disulfide exchange reaction. Injection of the conjugate into rabbits gave a
satisfactory antiserum to desmosine.
Assay conditions.
The sensitivity of an ELISA is dependent on both the dilution of antiserum and the con-
centration of hapten-protein conjugate used to coat the wells of the microtitration plate. While
a precise optimization of both these parameters is not necessary, a suitable combination of the
two parameters for routine analysis needs to be established.
Optimal antiserum dilution for the desmosine ELISA was established by testing serial
dilutions of the antiserum on plates coated with desmosine-KLH conjugate dissolved in the



















Fig. 2. Antiserum dilution curves. Either 1 /-tg/ml (0) or 5 /-tg/ml (e) of desmosine-KLH was coated
in the wells. Serial dilutions of the rabbit antiserum were added to the wells. The
amount of bound antibody was determined by incubating with alkaline phosphatase labled
IgG diluted 1:1000 and 2. 7mM p-nitrophenylphosphate. The enzyme activity was measured
by the absorbance at 405 nm.
coating buffer at concentrations of 1 and 5 t-tg/ml (Fig. 2). The amount of bound antibody was
determined by incubating with alkaline phosphatase labeled IgG diluted 1: 1, 000 and 2. 7 mM
p-nitrophenylphosphate as the substrate. As the antiserum dilution was increased to more than
1: 15, 000, the absorption at 405 nm by the enzyme reaction was observed within the absorbance
range of the microplatephotometer routinely used.
Then, a number of plates were coated with serially diluted desmosine-KLH conjugate from
234 5
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Fig. 3. The effect of concentration of coating conjugate on the amount of free desmosine which is
required for 50% inhibition of the reaction of the bound desmosine and the antibody. Using
the plates coated with serially diluted desmosine-KLH conjugate from 5 to 1 fLg/ml,
standard curves of desmosine were prepared from 0.02 ng to 100 ng with the usual blanks.
The standard curves were developed with antiserum diluted at 1: 15,000. The enzyme
activities were measured by the absorbance at 405 nm after incubating with alkaline
phosphatase labeled IgG diluted 1: 1000 and 2.7 mM p-nitrophenylphosphate.
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Fig. 4. The concentration of coating conjugate and the absorbance of blank solution. Using the
plates coated with serially diluted desmosine-KLH conjugate from 5 to 1 /Lg/ml, the enzyme
activities in the blank solution were determined as in Fig. 3. Antiserum diluted at 1: 15, 000
was used.
5 to 1 /Lg/ml and a standard curve of desmosine was prepared on each plate from O. 02 ng to
100 ng with the usual blanks. The standard curve was developed on each plate with antiserum
diluted at 1: 15. 000. Fig. 3 shows the effect of the concentration of coating conjugate on the
amount of free desmosine which is required for 50% inhibition of the reaction of the bound
desmosine and the antibody. With less concentrated coating conjugate, the free desmosine re-
quired for 50% inhibition was decreased. It is likely that the amount of desmosine required for
50% inhibition is constant when the coating conjugate concentration is reduced to l/Lg/ml or
less. However, the absorbance of blank solution decreased with the decrease of the coating
conjugate concentration (Fig. 4). The absorbance of blank solution obtained from plates coated
at l,ug/ml was too low for routine use. For this reason, 2/Lg/ml of desmosine-KLH conjugate
solution was selected as a suitable concentration of coating conjugate.
The optimum incubation time, dilution of alkaline phosphatase labeled IgG and concentration
of substrate were determined to obtain good response over the low concentration range of desmosine
within the absorbance range up to 2. The absorbance increased linearly with the incubation
time up to 2 h. However prolonged incubation was inclined to lead to a high background
absorbance relative to the maximal absorbance and to a loss of sensitivity. Therefore a incu-
bation time of 90 min was selected for routine use. Three plates were coated at 2,ug/m!. On
each plate three standard curves were developed with alkaline phosphatase labeled IgG diluted
at 1:1,000, 1:667 and 1:500, respectively. In addition, standard curves on the three plates were
developed with substrates of 2. 7, 4.0 and 5.4 mM, respectively. The increased concentratio of
alkaline phosphatase labeled IgG was quite effective in obtaining a better response. But the
effect of the concentration of the substrate on the color development was negligible over this
substrate concentration range. Therefore, a dilution of 1 :500 for alkaline phosphatase antibody
and 4 mM for substrate concentration were selected for routine use.























Fig. 5. The standard curve for desmosine ELISA. The absorbance at 405 nm is expressed as the
percentage of the maximum. The horizontal line shows the amount of test substance in-
cubated with the antiserum in the wells (plotted logarithmically). Linearity of inhibition
between 0.4 ng and 25 ng was obtained when desmosine (e) was used as test substance.
Isodesmosine (0) gave 4% cross reaction and lysine (0) gave <0.0003% cross-reaction.
Finally, the relation between the concentration of coating conjugate and the dilution of
antiserum was examined. One half of a plate was coated at 2 J-tg/ml and the other at 1 jLg/ml.
The standard curve of desmosine on the former was developed with antiserum diluted at 1:15,000
and the latter with antiserum diluted at 1: 7,500. The results showed that, with 2,ug/ml of
coating conjugate and 15, 000 dilution of antiserum, a good response was obtained over the
concentration range 0.4 ng to 25 ng. Therefore, the combination of 2 J-tg/ml of conjugate and
15, 000 dilution of antiserum was selected for routine use. A typical standard curve is shown
in Fig. 5.
5pecijicity.
The cross-reactivity of the antiserum with various amino acids was determined. Appreciable
cross-reactivity was found only with isodesmosine (4%) (Fig. 5). However, since this compound
is also specific to elastin, this slight cross-reaction did not decrease the usefulness of the method
in measuring elastin breakdown products. By contrast, an amino acid that is not unique to
elastin did not show any cross-reactivity with the antiserum.
Clinical application.
We measured urine desmosine/creatinine (Die) ratios to evaluate the usefulness of this
assay in clinical applications. The results are expressed as micrograms of desmosine per gram of
creatinine in urine samples collected over 24 h. Fig. 6 shows the results obtained from a group
of normal controls and 25 patients with COLD. The average values and standard deviations
for D /C in normal controls and patients with lung disease were 48 ± 18 and 216 ± 149, respecti-
vely. The difference between the average values is statistically significant (p < O. 001). The aver-
age 24 h desmosine excretion value in these patients was 168 ± 118 J-tg, whereas the average value
in the controls was 63 ± 31 ,ug. The difference between the average values is statistically signi-













































Fig. 6. Desmosine/creatinine ratios in 24 h urine of normal controls and patients with COLD.
Samples were assyed by the ELISA and autoanalyzer described in the text.
ficant (p< 0.01). This ELISA can detect as little as 0.4 ng of desmosine and, with slight
modifications, could probably be extended to even lower values. In triplicate determinations the
assay is reproducible to within 3%. These results show that this sensitive and specific ELISA
for desmosine could be used to monitor lung elastolysis in humans.
DISCUSSION
Proteolysis of the elastic fibers of the lung is considered to be the primary cause of pulmo-
nary emphysema (19). Degradation of elastin in the human lungs may be monitored by exami-
ning the level of urinary desmosine, an elastin-specific crosslinking amino acid. Hare! et al. (5)
measured the amount of desmosine excreted in the human urine by radioimmunoassay, and
found that the daily excretion is increased in patients with chronic obstructive lung disease
(COLD) compared to healthy individuals. Urinary desmosine has also been reported to be in-
creased in smokers and pneumonia patients. Davies et al. (20), however, did no observe signifi-
cant differences in urinary desmosine excretion between smokers and non-smokers, and ascribed
their results to insufficiency of the sensitivity of the measuring technique for evaluation of
elastolysis.
For radioimmunoassay, Hare! et al. obtained anti-desmosine antibodies by sensitizing
rabbits using a conjugate of desmosine and bovine serum albumin (BSA) prepared in the
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presence of 1-ethyl-3(3-dimethylaminopropyl) carbodiimide (ECDI). By this method, however,
the antigenicity of the conjugate is so weak that King et al. (21) reported that the antisera
were obtained from only 2 of the 4 inoculated rabbits. The rate of successful sensitization was
also less than 50% in our study. We, therefore, first reacted desmosine with SPDP as a coup-
ling agent, and SPDP-monoacylated desmosine was selectively conjugated with BGG uing a
Sephadex G-25 column. By this procedure, the binding linkage between BGG and desmosine
became longer, and since desmosine was sufficiently exposed on the molecular surface, a high-
actIvIty homogeneous antigen could be obtained. As compared to 40 desmosine molecules
bound to 1 mole of BSA when desmosine is conjugated with BSA using ECDI, 10 desmosine
molecules are bound to 1 mole of BGG by our method.
The measurement was made by the inhibition technique of enzyme-linked immunosorbent
assay (ELISA) using no radioisotopes so that the procedure can be carried out routinely in
clinical laboratories. To eliminate non-specific inhibition due to the reaction of contaminants
such as amino acids contained in the sampIes, the samples were applied prior to the measure-
ment to a CFll cellulose mini-column for partial purification of desmosine. This manipulation
sufficiently decreased the background level.
In this study, the daily urinary desmosine excretion was higher in most of the COLD
patients than in healthy individuals. Our results, which were consistent with those of Hare! et
al. (5), are considered to indicate increased elastolysis in the lung. However, a considerable
variation was observed in desmosine excretion among COLD patients, the cause of which is as
yet unknown.
Weare planning to investigate the possible relationships between urinary desmosine excre-
tion and clinical features in patients with pulmonary disorders other then COLD as well as
cardiovascular diseases. Our ELISA method is considered to be suited for such studies.
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